Home / What’s new? / Patents

Patents

Sort by:
YearTitle
DescendingAscending
Patent

Preparation of Biaryls

Number
WO 2009/003650
Year
2009
Customer
Bayer Cropscience
Symeres authors
Eric Damen
Patent

A method for the preparation of an enantiomerically pure benzazepine

Number
WO 2008/125577
Year
2008
Customer
Organon
Symeres authors
Jean-Paul Seerden
Patent

HIV Replication Inhibiting Purine Derivatives

Number
WO 2005028479
Year
2005
Customer
Janssen Pharma-ceutica N.V. (CMD)
Symeres authors
Ruben Leenders, Dirk Vandenput
Patent

Substituted 3-pyrrolidin-indole derivatives

Number
WO 2005019208
Year
2005
Customer
Grünenthal
Symeres authors
Edward Bijsterveld
Patent

HIV Inhibiting 1,2,4-Triazines

Number
WO 2004074266
Year
2004
Customer
Janssen Pharma-ceutica N.V. (CMD)
Symeres authors
Ruben Leenders
Patent

Method of preparation of a precursor oligocene

Number
WO 2004083160 A1 20040930
Year
2004
Customer
Philips
Symeres authors
Wolter ten Hoeve
Patent

N-Phenyl-(4-pyridyl)-Azinylamine Derivatives as Plant Protection Agents

Number
WO 2004/084634
Year
2004
Customer
Syngenta
Symeres authors
Ruud Titulaer
Patent

Processes for the Preparation of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Number
WO 2004016581
Year
2004
Customer
Janssen Pharma-ceutica N.V. (CMD)
Symeres authors
Ruben Leenders
Patent

HIV Replication Inhibitors

Number
US 20030171374
Year
2003
Customer
Janssen Pharma-ceutica N.V. (CMD)
Symeres authors
Ruben Leenders
Patent

Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer

Number
US7176315 B2
Year
2002
Customer
Pfizer Inc.
Symeres authors
Kees Pouwer
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
Scroll to top